About Us

Mission Statement

CHS Pharma is dedicated to the commercialization of an innovative treatment for a precancerous skin condition commonly known as Actinic Keratosis.

Background


  • In October 2005, CHS Pharma entered into a licensing agreement with Florida Atlantic University (FAU)    Research Corporation.
  • CHS Pharma’s efforts are based on discoveries made by Dr. Herbert Weissbach, Director of the Center for Molecular Biology & Biotechnology
  • CHS Pharma’s research and management team have a successful track record in the pharmaceutical and medical industry.

News

CHS Pharma, 500 Maplewood Drive,Suite 5A, Jupiter, FL 33458 | Fax : 561-748-9366 | Email : info@chspharma.com
© 2012 CHS Pharma. All rights reserved.,Website Designer : Ad Agency